Background: Drug-drug interactions (DDIs) can cause patient harm. Between 46 and 90% of patients admitted to the Intensive Care Unit (ICU) are exposed to potential DDIs (pDDIs). This rate is twice as high as patients on general wards. Clinical decision support systems (CDSSs) have shown their potential to prevent pDDIs. However, the literature shows that there is considerable room for improvement of CDSSs, in particular by increasing the clinical relevance of the pDDI alerts they generate and thereby reducing alert fatigue. However, consensus on which pDDIs are clinically relevant in the ICU setting is lacking. The primary aim of this study is to evaluate the effect of alerts based on only clinically relevant interactions for the ICU settin...
Purpose: To describe prevalence and patterns of potential drug-drug interactions (pDDIs) in the inte...
Background/aim: Drug-drug interactions (DDIs) can impact patient safety. Occurrence of clinically im...
0Background/aim: Drug drug interactions (DDIs) can impact patient safety. Occurrence of clinically i...
BACKGROUND: Drug-drug interactions (DDIs) can cause patient harm. Between 46 and 90% of patients adm...
Background: Drug-drug interactions (DDIs) can cause patient harm. Between 46 and 90% of patients adm...
PURPOSE: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intens...
Purpose: Potential drug-drug interactions (pDDIs) may harm patients admitted to the Intensive Care U...
Purpose: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intens...
Purpose: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intens...
PURPOSE: Potential drug-drug interactions (pDDIs) may harm patients admitted to the Intensive Care U...
PURPOSE: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intens...
Purpose: Potential drug-drug interactions (pDDIs) may harm patients admitted to the Intensive Care U...
Background Adverse drug events may occur as a result of drug–drug interactions (DDIs). Information t...
Purpose: To describe prevalence and patterns of potential drug-drug interactions (pDDIs) in the inte...
Background/aim: Drug-drug interactions (DDIs) can impact patient safety. Occurrence of clinically im...
0Background/aim: Drug drug interactions (DDIs) can impact patient safety. Occurrence of clinically i...
BACKGROUND: Drug-drug interactions (DDIs) can cause patient harm. Between 46 and 90% of patients adm...
Background: Drug-drug interactions (DDIs) can cause patient harm. Between 46 and 90% of patients adm...
PURPOSE: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intens...
Purpose: Potential drug-drug interactions (pDDIs) may harm patients admitted to the Intensive Care U...
Purpose: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intens...
Purpose: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intens...
PURPOSE: Potential drug-drug interactions (pDDIs) may harm patients admitted to the Intensive Care U...
PURPOSE: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intens...
Purpose: Potential drug-drug interactions (pDDIs) may harm patients admitted to the Intensive Care U...
Background Adverse drug events may occur as a result of drug–drug interactions (DDIs). Information t...
Purpose: To describe prevalence and patterns of potential drug-drug interactions (pDDIs) in the inte...
Background/aim: Drug-drug interactions (DDIs) can impact patient safety. Occurrence of clinically im...
0Background/aim: Drug drug interactions (DDIs) can impact patient safety. Occurrence of clinically i...